Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hecht, S S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hecht, S S
Related Collections
Right arrow Environmental tobacco smoke
Tobacco Control 2004;13:i48
© 2004 BMJ Publishing Group Ltd


RESEARCH PAPER

Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke

S S Hecht

Correspondence to:
Professor Stephen S Hecht
University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware Street SE, Minneapolis, MN 55455, USA; hecht002{at}umn.edu

Objective: To review the literature on carcinogen derived biomarkers of exposure to secondhand tobacco smoke (SHS). These biomarkers are specifically related to known carcinogens in tobacco smoke and include urinary metabolites, DNA adducts, and blood protein adducts.

Method: Published reviews and the current literature were searched for relevant articles.

Results: The most consistently elevated biomarker in people exposed to SHS was 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-Gluc), urinary metabolites of the tobacco specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). The tobacco specificity of this biomarker as well as its clear relation to an established lung carcinogen are particularly appropriate for its application in studies of SHS exposure.

Conclusion: The results of the available carcinogen derived biomarker studies provide biochemical data which support the conclusion, based on epidemiologic investigations, that SHS causes lung cancer in non-smokers.


Keywords: secondhand smoke; carcinogens; biomarkers

Abbreviations: 8-OH-dG, 8-hydroxydeoxyguanosine; BaP, benzo[a]pyrene; GC-MS, gas chromatography-mass spectrometry; HPB, 4-hydroxy-1-(3-pyridyl)-1-butanone; IARC, International Agency for Research on Cancer; NNAL, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol; NNK, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; NNN, N'-nitrosonornicotine; PAH, polycyclic aromatic hydrocarbons; SHS, secondhand smoke; SS, sidestream smoke; ttMA, trans,trans-muconic acid




This article has been cited by other articles:


Home page
CarcinogenesisHome page
E. M. Leslie, G. Ghibellini, K.-i. Nezasa, and K. L.R. Brouwer
Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR ) Wistar rats
Carcinogenesis, December 1, 2007; 28(12): 2650 - 2656.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. F. Schick and S. Glantz
Concentrations of the Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Sidestream Cigarette Smoke Increase after Release into Indoor Air: Results from Unpublished Tobacco Industry Research
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1547 - 1553.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. A. Granville, N. Warfel, J. Tsurutani, M. C. Hollander, M. Robertson, S. D. Fox, T. D. Veenstra, H. J. Issaq, R. I. Linnoila, and P. A. Dennis
Identification of a Highly Effective Rapamycin Schedule that Markedly Reduces the Size, Multiplicity, and Phenotypic Progression of Tobacco Carcinogen-Induced Murine Lung Tumors
Clin. Cancer Res., April 1, 2007; 13(7): 2281 - 2289.
[Abstract] [Full Text] [PDF]


Home page
J Health PsycholHome page
K. H. Ginzel, G. S. Maritz, D. F. Marks, M. Neuberger, Jim. R. Pauly, J. R. Polito, R. Schulte-Hermann, and T. A. Slotkin
Critical Review: Nicotine for the Fetus, the Infant and the Adolescent?
J Health Psychol, March 1, 2007; 12(2): 215 - 224.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. K. Hatsukami, C. T. Le, Y. Zhang, A. M. Joseph, M. E. Mooney, S. G. Carmella, and S. S. Hecht
Toxicant Exposure in Cigarette Reducers versus Light Smokers
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2355 - 2358.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Airoldi, P. Vineis, A. Colombi, L. Olgiati, C. Dell'Osta, R. Fanelli, L. Manzi, F. Veglia, H. Autrup, A. Dunning, et al.
4-Aminobiphenyl-Hemoglobin Adducts and Risk of Smoking-Related Disease in Never Smokers and Former Smokers in the European Prospective Investigation into Cancer and Nutrition Prospective Study
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2118 - 2124.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
O. E. Tulunay, S. S. Hecht, S. G. Carmella, Y. Zhang, C. Lemmonds, S. Murphy, and D. K. Hatsukami
Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1283 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
J B Richmond, D M Burns, and K M Cummings
Public health and the power of individual action
Tob. Control, March 1, 2004; 13(90001): i1 - 2.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.